International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care
Lisa M. Holle, Tegan Bilse, Ramatu Masud Alabelewe, Polly E. Kintzel, Esin Aysel Kandemir, Chia Jie Tan, Irene Weru, Carole Chambers, Roxanne Dobish, Evelyn Handel, Karunrat Tewthanom, Manit Saeteaw, Luh Komang Mela Dewi, Rowena Schwartz, M. Brooke Bernhardt, Manju Garg, Ashraf Chatterjee, Pinky Manyau, Alexandre Chan, Aygin Bayraktar‐Ekincioglu, Elif Aras‐Atik, R. Donald Harvey, Barry R. Goldspiel
Abstract
The Oncology Pharmacy Team (OPT), consisting of specialty-trained pharmacists and/or pharmacy technicians, is an integral component of the multidisciplinary healthcare team (MHT) involved with all aspects of cancer patient care. The OPT fosters quality patient care, safety, and local regulatory compliance. The International Society of Oncology Pharmacy Practitioners (ISOPP) developed this position statement to provide guidance on five key areas: 1) oncology pharmacy practice as a pharmacy specialty; 2) contributions to patient care; 3) oncology pharmacy practice management; 4) education and training; and 5) contributions to oncology research and quality initiatives to involve the OPT. This position statement advocates that: 1) the OPT be fully incorporated into the MHT to optimize patient care; 2) educational and healthcare institutions develop programs to continually educate OPT members; and 3) regulatory authorities develop certification programs to recognize the unique contributions of the OPT in cancer patient care.